|Year : 2016 | Volume
| Issue : 2 | Page : 449-452
A study to find depression in patients attending dermatological OPD in a teaching hospital
Abhinit Kumar1, Kunal Kumar1, Praneta Swarup2, Shitiz Goel3, Abhay Singh Tomar1
1 Department of Psychiatry, School of Medical Sciences and Research, Sharda Hospital, Greater Noida, Uttar Pradesh, India
2 Department of Pediatrics, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India
3 Department of Skin and VD, School of Medical Sciences and Research, Sharda Hospital, Greater Noida, Uttar Pradesh, India
|Date of Web Publication||18-Oct-2016|
Department of Psychiatry, School of Medical Sciences and Research, Sharda Hospital, Greater Noida, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
Introduction: The relationship between skin and the brain exists because the brain, as the center of psychological functions, and the skin have the same ectodermal origin and are affected by the same hormones and neurotransmitters. Skin disorder can be a potential source of emotional distress and psychiatric illness leading to impaired psychosocial adjustments. Aims and Objectives: The aim and objective of this study was to find psychiatric depression in patients attending dermatology outpatient department (OPD). Materials and Methods: The study was conducted in the department of psychiatry. A total of 200 patients of both gender were consecutively taken who referred to psychiatry OPD from skin OPD after meeting inclusion and exclusion criteria. Results: A total of 33.3% patients scored high on GHQ-12 Scale (General Health Questionnaire-12) and also clinically found that they were suffering from depression. Conclusion: Co-morbid Depression found in patients suffering from skin disorders. Proper screening and appropriate referral required for better prognosis.
Keywords: Depression, hormones, neurotransmitters, skin disorders
|How to cite this article:|
Kumar A, Kumar K, Swarup P, Goel S, Tomar AS. A study to find depression in patients attending dermatological OPD in a teaching hospital. J Family Med Prim Care 2016;5:449-52
|How to cite this URL:|
Kumar A, Kumar K, Swarup P, Goel S, Tomar AS. A study to find depression in patients attending dermatological OPD in a teaching hospital. J Family Med Prim Care [serial online] 2016 [cited 2019 May 24];5:449-52. Available from: http://www.jfmpc.com/text.asp?2016/5/2/449/192317
| Introduction|| |
The relationship between skin and the brain exists because the brain, as the center of psychological functions, and the skin have the same ectodermal origin and are affected by the same hormones and neurotransmitters. Skin disorder can be a potential source of emotional distress and psychiatric illness leading to impaired psychosocial adjustments. Emotional and psychosocial distress, in turn, may lead to psycho-somatic skin disorders. Dermatological diseases have a negative effect on the daily life, self-confidence, and self-respect. In fact, they may lead to questions on self-image, thus creating a problem of identity. Dermatologists have observed their patients to be relatively more concerned and worried about the diseases that are related to their physical appearance, as a result of which dermatology patients may be affected by disorders such as anxiety, depression, and other psychosocial problems.
The skin has long been recognized as the “organ of expression” and serves as the boundary between ourselves and the outside world. Psychological factors have long been known to be associated with dermatological conditions., At present, there is some literature on an association between adult skin disorders and psychosocial problems.,
Aims and objectives
The aim and objective of this study was to find out depression in patients attending dermatology outpatient department (OPD).
| Materials and Methods|| |
The study was conducted in the department of psychiatry. A total of 200 patients of both gender were consecutively taken who referred to psychiatry OPD from skin OPD after meeting inclusion and exclusion criteria. The study was conducted over a period of 6 months from February 2015 to July 2015.
The inclusion criteria were as follows:
- Patients >16 years of age
- Patients attending dermatology OPD
- Patients who have given written and informed consent.
The exclusion criteria were as follows:
- Patients <16 years of age
- Patients having any other medical illness
- Patients who have not given written and informed consent.
This was a cross-sectional study. All consecutive patients attending the dermatology OPD, fulfilling the inclusion criteria, were included in the study. The study was carried out in two phases. In the first phase, screening for psychiatric morbidity of all patients was done using the 12-item General Health Questionnaire (GHQ-12). Written informed consent was taken. In the second phase, patients who scored 3 or more on GHQ-12 were further evaluated for depression using Beck Depression Inventory (BDI-II) scale and also patients were examined clinically and diagnosed according to the International Classification of Diseases-10 (ICD-10) criteria.
| Results and Discussion|| |
A total of 200 patients attending dermatological OPD who gave informed consent and fulfilled the inclusion and exclusion criteria were included in this study. The study was carried out in two phases. In the first phase, screening for psychiatric morbidity of all patients was done using GHQ-12. In the second phase, patients scoring 3 or more on GHQ-12 were further evaluated for depression using BDI-II. A total of 54 patients out of 200 patients scored ≥3 on GHQ-12 and qualified for second phase [Table 1].
|Table 1: Distribution of total patients according to the General Health Questionnaire-12 score|
Click here to view
In our study, 33.3% of the patients scored high on scale (GHQ-12) and also clinically found that they were suffering from depression. The prevalence of depression was more in younger age group, i.e., 26–45 years.
Distribution of psychiatric morbidity according to age
When compared with the distribution of age, the study found no significant difference between the age groups in terms of increased psychiatric morbidity (GHQ score ≥ 3). However, higher percentage of GHQ score ≥3 (59.2%) was found in the age group of 26–45 years as compared to 25.9% in the age group of <25 years and 14.8% in the age group of >45 years [Table 2].
|Table 2: Distribution of gender according to the General Health Questionnaire-12 score|
Click here to view
Distribution of psychiatric morbidity according to sex/gender
When compared with the distribution of sex/gender, the study found no significant difference in psychiatric morbidity between the gender groups. However, higher percentage was found among men [Table 3]. Earlier study, conducted by Attah Johnson et al., also found no significant difference among genders in total psychiatric morbidity. However, they found comorbid depressive disorder more in female as compared to male patients and comorbid anxiety disorder more in male as compared to female patients.
|Table 3: Distribution of age according to the General Health Questionnaire-12 score|
Click here to view
Depression among dermatological patients
From the 54 patients who scored high on GHQ-12 scale, 18 (33.33%) patients were diagnosed having depressive disorder according to the BDI-II [Table 4]. This finding was supported by Gupta et al. They suggested that the degree of depressive psychopathology directly correlated with the severity of pruritus. They found that there is a direct correlation (P < 0.0001) between the Carroll Rating Scale for Depression and severity of pruritus. They concluded that the depressed clinical state may reduce the threshold for pruritus. In a similar study, Gupta et al. also observed that the degree of depressive psychopathology correlates positively with the severity of pruritus pretherapy. Prospectively, over the course of treatment, the change in depression correlated positively with the change in pruritus pre- to post-treatment. Felix et al. also found the prevalence of depressive disorder (50.75%) in dermatological patients. Devrimci-Ozguven et al. determined that psoriasis patients reported significantly higher degree of depression and more body cathexis problems than controls. In addition, the risk for developing psoriasis increased significantly in patients with moderate and severe depression. They also found a relationship between symptoms severity and low affective expression and high BDI scores. The study suggests that the relationship between psoriasis and psychological problems can be reciprocal and requires further investigation. Barankin and DeKoven  in their review article found that dermatologic problems could result in psychosocial effects that seriously affect patients' lives. Apart from cosmetic nuisance, skin disease could produce anxiety, depression, and other psychological problems that affect patients' lives in ways comparable to other illnesses causing disability. Fried et al., Hashiro and Okumura, and Kellett and Gawkrodger  also supported the opinion that skin diseases are strongly associated with depression. Gupta et al. emphasized that depressive disorder is one of the most frequently encountered psychiatric disorders in dermatology and it is associated with a high incidence of suicide. Ahmed et al. found that major depressive illness was the most frequent psychiatric illness followed by generalized anxiety, mixed anxiety and depression, social phobia, agoraphobia, and sexual dysfunction. They concluded that psychiatric caseness has a probable association with vitiligo, the frequency being influenced by variables of disease and life. Major depression and anxiety remain the most common psychiatric disorders in these patients.
|Table 4: Distribution of the Beck Depression Inventory score as per dermatological diagnosis|
Click here to view
| Conclusion|| |
- This study found comorbid depression in patients suffering from skin disorder. Other psychiatric illness were also present in these patients and it should be evaluated further on bigger population
- Dermatologists should be aware about the psychiatric illness, and appropriate referral should be made. This will help in making a proper diagnosis and better prognosis.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sack. Psychodermatology-The Psychological impact of skin disease. In: Walker C, Papadoulos L, Editors. Chapter-Introduction: 00-01. New York: Cambridge University Press; 2005.
Wilson A. Psychodermatology-The Psychological impact of skin disease. In: Walker C, Papadoulos L, Editors. Chapter-Introduction: 00-01. New York: Cambridge University Press; 2005.
Engles WD. Dermatologic disorders. Psychosomatics 1982;23:1209-19.
Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999;72(Pt 3):385-96.
Attah Johnson FY, Mostaghimi H. Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 1995;34:244-8.
Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40.
Gupta MA, Gupta AK, Kirkby S, Weiner HK, Mace TM, Schork NJ, et al.
Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988;124:1052-7.
Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:267-71.
Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician 2002;48:712-6.
Fried RG, Gupta MA, Gupta AK. Depression and skin disease. Dermatol Clin 2005;23:657-64.
Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: Comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 1997;14:63-7.
Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999;140:273-82.
Gupta MA, Gupta AK, Ellis CN, Koblenzer CS. Psychiatric evaluation of the dermatology patient. Dermatol Clin 2005;23:591-9.
Ahmed I, Ahmed S, Nasreen S. Frequency and pattern of psychiatric disorders in patients with vitiligo. J Ayub Med Coll Abbottabad 2007;19:19-21.
[Table 1], [Table 2], [Table 3], [Table 4]